Pharmaceuticals, Biotechnology and Life Sciences
$12 million in extension funding announced Karuna awarded U.S. Patent covering lead product candidate, KarXT BOSTON–(BUSINESS WIRE)–Karuna Therapeutics, Inc. (“Karuna”)…
Proceeds will be used to advance clinical development of lead product candidate, KarXT, for additional indications beyond the ongoing Phase…
PureTech Health and its affiliate Karuna have completed a $42 million Series A financing round, which will be used to…
The study, which will be conducted in up to 70 healthy individuals, aims to evaluate the tolerability of KarXT compared to xanomeline alone.